
Virtus Reaves Utilities ETF
$76.30−0.34 (−0.44%)
- 0.49%
- $1.16B
- −7.2%
- 1.61%
- 158K sh
- low $69.45high $85.83
The ETF.net UTES Grade
Score 66 out of 100
- 5 of 35
Score 66 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.A79 out of 100Rank 8 of 35Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.D30 out of 100Rank 27 of 35Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.A91 out of 100Rank 2 of 35Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.D39 out of 100Rank 28 of 35Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.A85 out of 100Rank 3 of 35
Our read on UTES
In short
BUtilities, but stock-picked. UTES has run an active, value-driven, bottom-up portfolio of electricity, gas and water companies since 2015, at a fee below what the typical active US equity ETF charges.
Stated mandate
The Fund seeks total return from capital appreciation and income.
Why people hold it
Worth knowing
UTES Holdings
- Other
- 19
- 70%
- CEG
Sectors
- Utilities100.0%
Geography
- United States100.00%
UTES Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Nov 2, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | UTES |
|---|---|
| Year to date | −2.3% |
| 1 month | +7.2% |
| 3 months | −1.3% |
| 1 year | −7.2% |
| 3 years | +22.7% |
| 5 years | +13.5% |
| 10 years | +12.4% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | UTES |
|---|---|---|
| 2026 YTD | −2.3% | |
| 2025 | +25.7% | |
| 2024 | +45.3% | |
| 2023 | −2.4% | |
| 2022 | +0.8% | |
| 2021 | +20.7% | |
| 2020 | −0.3% |
UTES in the news
UTES Dividends
- 1.61%
- $1.23
- $0.26 per share
- Quarterly
Distribution history
UTES Risk
- 20.0%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.96
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −20.4%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.74
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
FMP measures it over up to five years of monthly returns.
UTES Cost
Overpaying vs TRUF, tied cheapest in US Active Sector
$7,686
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
UTES 0.49%
$9,792
TRUF 0.10% Tied cheapest
$2,106
Cost over time
Year by year
| Year | UTES | TRUF | Overpaying |
|---|---|---|---|
| 10 | $883 | $183 | $700 |
| 20 | $3,394 | $717 | $2,677 |
| 30 | $9,792 | $2,106 | $7,686 |
Other funds in US Active Sector
- ATMEDT. Rowe Price Health Care ETFExpense ratio 0.44%1 year return +19.9%
- BTRUTVanEck Technology TruSector ETFExpense ratio 0.14%1 year return +9.6%
- BTRUCVanEck Communication Services TruSector ETFExpense ratio 0.14%1 year return
- BBMEDiShares Health Innovation Active ETFExpense ratio 0.55%1 year return +26.9%
- BLFSCF/M Emerald Life Sciences Innovation ETFExpense ratio 0.54%1 year return +31.6%

